Fundies.
English

Segment disclosures

Company overview

SANGAMO THERAPEUTICS, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 14 retained observations 10 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sgmo:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-311442000 USD20260514Open filing evidence
2025-01-01 – 2025-12-3139552000 USD20260330Open filing evidence
2025-07-01 – 2025-09-30581000 USD20251106Open filing evidence
2025-01-01 – 2025-09-3025324000 USD20251106Open filing evidence
2025-04-01 – 2025-06-3018306000 USD20250807Open filing evidence
2025-01-01 – 2025-06-3024743000 USD20250807Open filing evidence
2025-01-01 – 2025-03-316437000 USD20260514Open filing evidence
2024-01-01 – 2024-12-3157800000 USD20260330Open filing evidence
2024-07-01 – 2024-09-3049412000 USD20251106Open filing evidence
2024-01-01 – 2024-09-3050249000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30356000 USD20250807Open filing evidence
2024-01-01 – 2024-06-30837000 USD20250807Open filing evidence
2024-01-01 – 2024-03-31481000 USD20250512Open filing evidence
2023-01-01 – 2023-12-31176232000 USD20250317Open filing evidence